These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10598686)

  • 21. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
    de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
    J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season.
    Kamada M; Nagai T; Kumagai T; Igarashi M; Ihara T; Okafuji T; Ochiai H; Sakiyama H; Shimomura K; Suzuki E; Torigoe S; Miyazaki C; Miyata A; Yuri K; Ito Y; Nakayama T; Kase T; Okuno Y
    Vaccine; 2006 Apr; 24(17):3618-23. PubMed ID: 16530300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).
    Mast EE; Harmon MW; Gravenstein S; Wu SP; Arden NH; Circo R; Tyszka G; Kendal AP; Davis JP
    Am J Epidemiol; 1991 Nov; 134(9):988-97. PubMed ID: 1951297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Pan Y; Wang Q; Yang P; Zhang L; Wu S; Zhang Y; Sun Y; Duan W; Ma C; Zhang M; Zhang X; MacIntyre CR
    Vaccine; 2017 Dec; 35(51):7133-7138. PubMed ID: 29128383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
    Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
    Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic.
    Ohmit SE; Arden NH; Monto AS
    J Am Geriatr Soc; 1999 Feb; 47(2):165-71. PubMed ID: 9988287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of influenza vaccine in the elderly in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic.
    Deguchi Y; Takasugi Y; Tatara K
    J Med Microbiol; 2000 Jun; 49(6):553-556. PubMed ID: 10847209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an influenza hemagglutinin-diphtheria toxoid conjugate vaccine in elderly nursing home subjects during an influenza outbreak.
    Gravenstein S; Drinka P; Duthie EH; Miller BA; Brown CS; Hensley M; Circo R; Langer E; Ershler WB
    J Am Geriatr Soc; 1994 Mar; 42(3):245-51. PubMed ID: 8120307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
    Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
    Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.
    Nichol KL; Mendelman PM; Mallon KP; Jackson LA; Gorse GJ; Belshe RB; Glezen WP; Wittes J
    JAMA; 1999 Jul; 282(2):137-44. PubMed ID: 10411194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly.
    Treanor JJ; Mattison HR; Dumyati G; Yinnon A; Erb S; O'Brien D; Dolin R; Betts RF
    Ann Intern Med; 1992 Oct; 117(8):625-33. PubMed ID: 1530193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza epidemic among a community of elderly people in spite of vaccination.
    Dindinaud G; Potiron G; Agius G; Ferron V; Burucoa C; Bourgoin A; Grollier G; Peletier MP; Perivier E; Castets M
    Eur J Epidemiol; 1993 Nov; 9(6):667-70. PubMed ID: 8150072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza B outbreak among influenza-vaccinated welfare home residents in Singapore.
    Win MK; Chow A; Chen M; Lau YF; Ooi EE; Leo YS
    Ann Acad Med Singap; 2010 Jun; 39(6):448-52. PubMed ID: 20625620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of influenza A outbreaks in nursing homes: amantadine as an adjunct to vaccine--Washington, 1989-90.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Dec; 40(49):841-4. PubMed ID: 1961174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.
    Hara M; Tanaka K; Kase T; Maeda A; Hirota Y
    Vaccine; 2010 Aug; 28(35):5664-8. PubMed ID: 20600482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003.
    Besselaar TG; Botha L; McAnerney JM; Schoub BD
    J Med Virol; 2004 May; 73(1):71-8. PubMed ID: 15042651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.